{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:26:53Z","timestamp":1789694813739,"version":"4.0.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107691","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T17:50:23Z","timestamp":1412185823000},"page":"e107691","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Barbara","family":"Baldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Y.","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0891988710383573","article-title":"The clinical and genetic features of Huntington disease","volume":"23","author":"A Sturrock","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JHD-2012-120006","article-title":"Hypothalamic and limbic system changes in Huntington\u2019s disease","volume":"1","author":"A Petersen","year":"2012","journal-title":"Journal of Huntington\u2019s disease"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","article-title":"Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease","volume":"47","author":"SM de la Monte","year":"1988","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"GA Graveland","year":"1985","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0074-7696(04)40003-5","article-title":"Neuropeptides in hypothalamic neuronal disorders","volume":"240","author":"DF Swaab","year":"2004","journal-title":"Int Rev Cytol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"S Gabery","year":"2010","journal-title":"Acta neuropathologica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1750-3639.2008.00135.x","article-title":"Hypocretin and melanin-concentrating hormone in patients with Huntington disease","volume":"18","author":"A Aziz","year":"2008","journal-title":"Brain pathology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-8993(96)00080-7","article-title":"Somatostatin 1\u201312 immunoreactivity is decreased in the hypothalamic lateral tuberal nucleus of Huntington\u2019s disease patients","volume":"728","author":"HJ Timmers","year":"1996","journal-title":"Brain research"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/hmg\/ddi004","article-title":"Orexin loss in Huntington\u2019s disease","volume":"14","author":"A Petersen","year":"2005","journal-title":"Human molecular genetics"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nbd.2010.07.013","article-title":"Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis","volume":"40","author":"C Soneson","year":"2010","journal-title":"Neurobiology of disease"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study","volume":"131","author":"M Politis","year":"2008","journal-title":"Brain : a journal of neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits","volume":"13","author":"S Hult","year":"2011","journal-title":"Cell metabolism"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1093\/hmg\/ddt203","article-title":"Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington\u2019s disease","volume":"22","author":"S Hult Lundh","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"M Gray","year":"2008","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbr.2012.10.039","article-title":"Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington\u2019s disease","volume":"238","author":"YS Abada","year":"2013","journal-title":"Behav Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e51168","DOI":"10.1371\/journal.pone.0051168","article-title":"Expression of mutant huntingtin in leptin receptor-expressing neurons does not control the metabolic and psychiatric phenotype of the BACHD mouse","volume":"7","author":"SH Lundh","year":"2012","journal-title":"PloS one"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature11705","article-title":"Central nervous system control of metabolism","volume":"491","author":"MG Myers Jr","year":"2012","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1210\/en.2007-1200","article-title":"Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome","volume":"149","author":"NC Bingham","year":"2008","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2826.2011.02174.x","article-title":"Steroidogenic factor 1 and the central nervous system","volume":"24","author":"T Budefeld","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/dvdy.1116","article-title":"Comparative localization of Dax-1 and Ad4BP\/SF-1 during development of the hypothalamic-pituitary-gonadal axis suggests their closely related and distinct functions","volume":"220","author":"Y Ikeda","year":"2001","journal-title":"Dev Dyn"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/me.2008-0034","article-title":"Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior","volume":"22","author":"L Zhao","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yfrne.2006.02.002","article-title":"Development of the ventromedial nucleus of the hypothalamus","volume":"27","author":"KM McClellan","year":"2006","journal-title":"Front Neuroendocrinol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cne.23226","article-title":"Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH","volume":"521","author":"CC Cheung","year":"2013","journal-title":"J Comp Neurol"},{"key":"ref26","first-page":"478","article-title":"The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus","volume":"9","author":"Y Ikeda","year":"1995","journal-title":"Mol Endocrinol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.12.021","article-title":"Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis","volume":"49","author":"H Dhillon","year":"2006","journal-title":"Neuron"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"10673","DOI":"10.1073\/pnas.1102364108","article-title":"Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus","volume":"108","author":"KW Kim","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1210\/me.2008-0127","article-title":"Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus","volume":"22","author":"KW Kim","year":"2008","journal-title":"Mol Endocrinol"},{"key":"ref30","first-page":"71","article-title":"Revisiting the Ventral Medial Nucleus of the Hypothalamus: The Roles of SF-1 Neurons in Energy Homeostasis","volume":"7","author":"YH Choi","year":"2013","journal-title":"Front Neurosci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"MA Pouladi","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/nm.3514","article-title":"Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington\u2019s disease","volume":"20","author":"N Wang","year":"2014","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"AA Walf","year":"2007","journal-title":"Nat Protoc"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1113\/jphysiol.2012.239798","article-title":"Differential effects of early environmental enrichment on emotionality related behaviours in Huntington\u2019s disease transgenic mice","volume":"591","author":"T Renoir","year":"2013","journal-title":"J Physiol"},{"key":"ref35","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"RD Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"MA Pouladi","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1210\/rp.57.1.19","article-title":"Steroidogenic factor 1: an essential mediator of endocrine development","volume":"57","author":"KL Parker","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2010.11.019","article-title":"SF-1 in the ventral medial hypothalamic nucleus: a key regulator of homeostasis","volume":"336","author":"KW Kim","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"ref39","first-page":"135","article-title":"Mood disorders in Huntington\u2019s disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"P Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","article-title":"Choosing an animal model for the study of Huntington\u2019s disease","volume":"14","author":"MA Pouladi","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"ref41","first-page":"81","article-title":"A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington\u2019s Disease Gene Mutation","volume":"4","author":"X Du","year":"2013","journal-title":"Front Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression-related behavior in the R6\/1 transgenic mouse model of Huntington\u2019s disease","volume":"18","author":"TY Pang","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"JM Van Raamsdonk","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","article-title":"Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice","volume":"15","author":"A Lloret","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington\u2019s disease transgenic and knock-in mouse models","volume":"35","author":"L Menalled","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brainresbull.2007.06.003","article-title":"GABA\/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze","volume":"74","author":"CH Bueno","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cne.903480103","article-title":"Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat","volume":"348","author":"NS Canteras","year":"1994","journal-title":"J Comp Neurol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cen.12054","article-title":"A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and\/or depression","volume":"78","author":"AS Suwanai","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ar.1090780203","article-title":"Hypothalamic lesions and adiposity in the rat","volume":"78","author":"AW Hetherington","year":"1940","journal-title":"Anat Rec"},{"key":"ref50","first-page":"285","article-title":"Sympathetic activity and food intake of rats with ventromedial hypothalamic lesions","volume":"12","author":"T Sakaguchi","year":"1988","journal-title":"Int J Obes"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0031-9384(74)90260-1","article-title":"Independence of food intake and obesity following ventromedial hypothalamic lesions in the rat","volume":"13","author":"BM Rabin","year":"1974","journal-title":"Physiol Behav"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"JM Van Raamsdonk","year":"2006","journal-title":"Hum Mol Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T09:37:26Z","timestamp":1717407446000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107691"}},"subtitle":[],"editor":[{"given":"Hoon","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107691","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}